| Results summary | View all lists in L2L MDB | View all genes in R01AD.profile.ud50 |
|
Upregulated in VHL-null renal carcinoma vs. normal renal cells (Fig. 2c+e) enrichment: 2.41-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 217739_S_AT | PBEF1 | G | C | S | pre-B-cell colony enhancing factor 1 | ||||||||
| 217838_S_AT | EVL | T | D | X | P | S | Enah/Vasp-like | ||||||
| 209185_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
| 204999_S_AT | ATF5 | G | R | activating transcription factor 5 | |||||||||
| 204998_S_AT | ATF5 | G | R | activating transcription factor 5 | |||||||||
| 209121_X_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
| 208937_S_AT | ID1 | D | R | S | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | ||||||||
| 209184_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
| 202968_S_AT | DYRK2 | P | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 | ||||||||||